openPR Logo
Press release

Sarcopenia Treatment Market: Upcoming Demands and Growth Analysis 2025

08-08-2017 05:40 AM CET | Health & Medicine

Press release from: Transparency Market Research

Sarcopenia Treatment Market

Sarcopenia Treatment Market

Sarcopenia is the loss of muscle mass and muscle strength as a person reaches age thirty or more, in response to aging, affecting the level of activity and quality of life. It has been identified in three stages in older people: presarcopenia-loss of muscle mass, sarcopenia-loss of muscle which can affect either physical performance or physical strength, and severe sarcopenia-loss of muscle mass that affects both physical performance and strength. According to The Sports Journal, it has been found that approximately 0.5% to 1.0% muscle mass is lost every year after the age of 70. This loss of muscle mass is reported as 4.7% decrease in men and 3.7% decrease in women per decade. This loss of muscle mass leads to decrease in muscle function with increased chances of functional impairment, disability, and mortality in the elderly. In the year 2000, the cost attributed to sarcopenia was 1.5% of the total healthcare expenditure. It was estimated that 10% reduction in the occurrence of sarcopenia could save US$ 1.1 billion worth healthcare expenditure. Identification of sarcopenia can be done through numerous techniques to measure muscle mass, involving chemical composition, imaging (computed tomography [CT], magnetic resonance imaging [MRI] and dual-energy x-ray absorptiometry [DXA]), anthropometry or hydrostatic weighing. Amongst these, DXA is the most preferred technique.

This report gives readers a comprehensive overview of the Sarcopenia Treatment Market:
http://www.transparencymarketresearch.com/sarcopenia-treatment-market.html

To overcome the symptoms of sarcopenia, an individual has to routinely do weight lifting and strength building exercises. Progressive Resistance Training (PRT) is the most suitable exercise in this condition and it should be performed as the primary action for the treatment of sarcopenia. The sarcopenia treatment market is forecasted to grow in the future as a result of increasing rate of obesity throughout the world as obesity disturbs the metabolic function of the body. According to NIH, almost 3 of 4 people are deemed to be obese. The prevalence of obesity is similar in men and women (about 36 percent). Currently, sarcopenia treatment comprises only off label and generic drugs like estrogen, progesterone, and some growth hormones. There are no promising drugs in the pipeline for the treatment of sarcopenia. Therefore, the global sarcopenia treatment market is forecasted to see sluggish growth due to unavailability of new drugs in the near future. Despite low market assessment, pharmaceutical companies such as GSK and Five Prime Therapeutics have signed a collaboration agreement to develop therapies for sarcopenia. They are focused on developing a new class of drugs called SARMs (selective androgen receptor modulators) to prevent and treat muscle wasting or muscle loss conditions like chronic sarcopenia and cancer.

Get accurate market forecast and analysis on the Sarcopenia Treatment Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28547

Increased aging and obesity are the driving factors responsible for the growth of the sarcopenia treatment market. Furthermore, lack of a permanent cure for the treatment of sarcopenia, increased R & D development through government policies, changes in disease management etc. are factors anticipated to drive the growth of the sarcopenia treatment market.

Geographically, the sarcopenia treatment market is segmented into North America, Latin America, Europe, and Asia Pacific (excluding Japan), and the Middle East & Africa. North America followed by Europe has the largest market share owing to the availability and affordability of expensive tests and therapies in this region. Rising population, increased research activities, and awareness in developing countries such as India and China are the factors contributing to the growth of the sarcopenia treatment market in Asia.

The major players in the global sarcopenia treatment market are GlaxoSmithKline, Radius Health, Inc. and Five Prime Therapeutics, Inc. who are involved in the development of SARMs (selective androgen receptor modulators) class of drugs.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sarcopenia Treatment Market: Upcoming Demands and Growth Analysis 2025 here

News-ID: 655495 • Views: 633

More Releases from Transparency Market Research

Venous Diseases Treatment Market to Expand at a CAGR of 6.8% from 2022 - 2031
Venous Diseases Treatment Market: Overview The venous diseases treatment market is estimated to attain a valuation of US$ 11.3 Bn by 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.8% from 2022 to 2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of
Medical Imaging Equipment Services Market Future Scope Analysis Report 2022-2031
Medical Imaging Equipment Services Market: Overview The medical imaging equipment services market is estimated to attain a valuation of US$ 29.2 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.1% from 2022 to 2031. The key objective of the TMR report is to offer a complete assessment of the global market including
Geriatric Care Services Market Revenue Share Detailed Analysis Report 2021-2028
Geriatric Care Services Market: Overview The geriatric care services market is estimated to attain a valuation of US$ 0.7 Bn by the end of 2028, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.3% from 2021 to 2028. The key objective of the TMR report is to offer a complete assessment of the global market including major
Medical Device Technologies Market - Current Trends and Future Opportunities Ana …
Medical Device Technologies Market: Overview The medical device technologies market is estimated to attain a valuation of US$ 662.7 Bn by the end of 2028, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.3% from 2021 to 2028. The key objective of the TMR report is to offer a complete assessment of the global market including major

All 5 Releases


More Releases for Sarcopenia

The Sarcopenia Treatment Market to be digitally servile
The Sarcopenia Treatment Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent
Sarcopenia Market Scope Emerging Trends, Analysis and Forecast 2026
The report published on the “Sarcopenia Market Scope Emerging Trends, Analysis and Forecast 2026” by Zion Market Research facilitates a closer outlook on opportunities, revenue growth, and current market trends. The report is focused to offer qualitative and quantitative analysis of dynamics and market opportunities prevailing during the forecast period. Also, the report encompasses an in-depth study on the prominent leaders in the Sarcopenia Market. The Leading Market Players Covered
Sarcopenia Treatment Market to Witness Significant Incremental Opportunity
According to a recent report published by Research Dive, titled, "Sarcopenia Treatment Market by Type, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the global Sarcopenia Treatment market size was valued at $ 2742.4 million in 2018, and is projected to reach $ 3975.0 million by 2026, registering a CAGR of 4.7% from 2018 to 2026. North America dominates the market, followed by Europe, Asia-Pacific, Latin America, Middle East and
Sarcopenia Treatment Market Analysis & Key Trends 2025
Sarcopenia which results in the decrease of lean muscle mass when the person reaches age thirty or above, she or he could expect the gradual loss of muscle tissues due to increasing aging altering the level of activity and also affecting the quality of life. Aging leads to change in metabolic activity which includes the decrease in synthesis of muscle protein and little change in the degradation. Sarcopenia affects
Sarcopenia Pipeline Review H2 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Pipeline Review, H2 2017, provides an overview of the Sarcopenia (Musculoskeletal Disorders) pipeline landscape. Sarcopenia is defined as the loss of mass and muscular function with age. Symptoms include obesity, difficulty walking or moving about, lack of strength and respiratory problems. Treatment includes medications and hormone replacement therapy. Publisher's Pharmaceutical and Healthcare latest pipeline guide Sarcopenia - Pipeline Review, H2 2017,
Sarcopenia - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Sarcopenia - Pipeline Review, H2 2017”. Sarcopenia is defined as the loss of mass and muscular function with age. Symptoms include obesity, difficulty walking or moving about, lack of strength and respiratory problems. Treatment includes medications and hormone replacement therapy.  Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246572 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide